BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Emily Rodrigues, Matthew Macauley. Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic OpportunitiesCancers 2018; 10(6): 207 doi: 10.3390/cancers10060207
2
Bo Ren, Ming Cui, Gang Yang, Huanyu Wang, Mengyu Feng, Lei You, Yupei Zhao. Tumor microenvironment participates in metastasis of pancreatic cancerMolecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0858-1
3
Jérémy Nigri, Meritxell Gironella, Christian Bressy, Elena Vila-Navarro, Julie Roques, Sophie Lac, Caroline Bontemps, Coraline Kozaczyk, Jérôme Cros, Daniel Pietrasz, Raphaël Maréchal, Jean-Luc Van Laethem, Juan Iovanna, Jean-Baptiste Bachet, Emma Folch-Puy, Richard Tomasini. PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic markerCellular and Molecular Life Sciences 2017; 74(22): 4231 doi: 10.1007/s00018-017-2579-9
4
Noriyuki Hirahara, Yoshitsugu Tajima, Takeshi Matsubara, Yusuke Fujii, Shunsuke Kaji, Yasunari Kawabata, Ryoji Hyakudomi, Tetsu Yamamoto, Yuki Uchida, Takahito Taniura. Systemic Immune-Inflammation Index Predicts Overall Survival in Patients with Gastric Cancer: a Propensity Score–Matched AnalysisJournal of Gastrointestinal Surgery 2020;  doi: 10.1007/s11605-020-04710-7
5
A. Fucic, A. Aghajanyan, Z. Culig, N. Le Novere. Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate CancerPathology & Oncology Research 2019; 25(4): 1269 doi: 10.1007/s12253-018-0467-8
6
Dominique Lombardo, Françoise Silvy, Isabelle Crenon, Emmanuelle Martinez, Aurélie Collignon, Evelyne Beraud, Eric Mas. Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?Oncotarget 2018; 9(15): 12513 doi: 10.18632/oncotarget.23619
7
Shahed N. Badiyan, Jason K. Molitoris, Michael D. Chuong, William F. Regine, Adeel Kaiser. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant SettingsSurgical Oncology Clinics of North America 2017; 26(3): 431 doi: 10.1016/j.soc.2017.01.012
8
Noriyuki Hirahara, Yoshitsugu Tajima, Yusuke Fujii, Tetsu Yamamoto, Ryoji Hyakudomi, Takanori Hirayama, Takahito Taniura, Kazunari Ishitobi, Akihiko Kidani, Yasunari Kawabata. A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell CarcinomaWorld Journal of Surgery 2018; 42(1): 172 doi: 10.1007/s00268-017-4144-y
9
Sariah A. Kell, Melissa A. Kachura, Alex Renn, Paula Traquina, Robert L. Coffman, John D. Campbell. Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cellsInternational Immunopharmacology 2019; 66: 296 doi: 10.1016/j.intimp.2018.11.019
10
Shumin Qiu, Chongmin Jiang, Lin Zhou. Physical activity and mortality in patients with colorectal cancerEuropean Journal of Cancer Prevention 2020; 29(1): 15 doi: 10.1097/CEJ.0000000000000511
11
Yan-Bo Zheng, Meng-Ran Zhang, Yi Li, Xiu-Jun Liu, Yong-Su Zhen. DBDx-based drug combinations show highly potent therapeutic efficacy against human pancreatic cancer xenografts in athymic miceCancer Biology & Therapy 2020; : 1 doi: 10.1080/15384047.2020.1776580